Green Abiotechnology co., Ltd
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Development of antibody additives for aquaculture and livestock, development of antibody equipment for breeding source purification, development of antibodies for biotechnology research, development of antibody therapeutics for pets, development of antibodies for biomedical diagnostics, and research and development of targeted cancer drugs.
The content above was translated by Ai
Founded Year
2015
Unified Business No.
24845922
Status
Active
Number of Employees
0
Total Paid-in
Capital
24,340,000 (NT$)
Location of Company
Taiwan
, Taichung City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
We are a company focusing on antibody research and development, utilizing patented technology to develop new types and new applications of antibodies. Utilizing our company's patented technology, we develop monoclonal antibodies (Multivalent Monoclonal Antibodies) that possess high specificity, high titer, and even multiple targets. Utilizing the patented technology of Green Abiotechnology co., Ltd, we can help customers produce monoclonal antibodies that were previously difficult to develop, which can then be applied in fields such as medicine, testing, academic research, and environmental purification.
The technology of Green Abiotechnology co., Ltd mainly originates from the successful collaborative development of a rapid screening method for monoclonal antibodies by Tunghai University, Chung Shan Medical University, and the National Laboratory Animal Center. This method produces monoclonal antibody-producing cell lines with high specificity and high titer for different species and different targets. Through the promotion of Professor Chang-Chi Hsieh from the Department of Animal Science at Tunghai University, who is one of the inventors, this technology was transferred to Green Abiotechnology co., Ltd, and can be applied in fields such as antibody research and development, production, and application.
The predecessor of Green Abiotechnology co., Ltd, the "Green Antibody" entrepreneurial team, participated in the talent cultivation program implemented by the "Tunghai University Agricultural Biotechnology Industry Teaching and Internship Promotion Center" subsidized by the Ministry of Education in 2014, embarking on their entrepreneurial journey. Based on this rapid monoclonal antibody screening technology, they participated in the Ministry of Education's Biotechnology Industry Innovation and Entrepreneurship Talent Cultivation Program and the 2014 Biotech Supernova Entrepreneurship Competition, winning the Bronze Award in the Agricultural Biotechnology Category. In March of this year, Green Abiotechnology co., Ltd was established under the guidance of the Tunghai University Incubator Center and the Agricultural Biotechnology Industry Teaching and Internship Promotion Center.
The technology of Green Abiotechnology co., Ltd mainly originates from the successful collaborative development of a rapid screening method for monoclonal antibodies by Tunghai University, Chung Shan Medical University, and the National Laboratory Animal Center. This method produces monoclonal antibody-producing cell lines with high specificity and high titer for different species and different targets. Through the promotion of Professor Chang-Chi Hsieh from the Department of Animal Science at Tunghai University, who is one of the inventors, this technology was transferred to Green Abiotechnology co., Ltd, and can be applied in fields such as antibody research and development, production, and application.
The predecessor of Green Abiotechnology co., Ltd, the "Green Antibody" entrepreneurial team, participated in the talent cultivation program implemented by the "Tunghai University Agricultural Biotechnology Industry Teaching and Internship Promotion Center" subsidized by the Ministry of Education in 2014, embarking on their entrepreneurial journey. Based on this rapid monoclonal antibody screening technology, they participated in the Ministry of Education's Biotechnology Industry Innovation and Entrepreneurship Talent Cultivation Program and the 2014 Biotech Supernova Entrepreneurship Competition, winning the Bronze Award in the Agricultural Biotechnology Category. In March of this year, Green Abiotechnology co., Ltd was established under the guidance of the Tunghai University Incubator Center and the Agricultural Biotechnology Industry Teaching and Internship Promotion Center.
The content above was translated by Ai
